gene signature of the early hypoxia for the prediction of the patient via life

摘要

A method of predicting of the patient response to a cancer treatment, comprising:Measuring the gene expression levels of a plurality of genes selected from the groups consisting of the defined groups a, b and c, in a biological sample from a patient:a. group consisting of a: gene, which correspond to transcripts that, with the following the unigene - id - nos.. are connected: hs.592692, hs.633514, hs.127126, hs.334587, hs.648626, hs.646346, hs.584803, hs.567495, hs.651126, hs.478746, hs.72550, hs.154276, hs.233568, hs.106861, hs.414418, hs.593565, hs.235116, hs.554791, hs.226780, hs.525549, hs.536158, hs.438489, hs.643279, hs.189772, hs.78977, hs.155983, hs.612872, hs.435933, hs.489603, hs.128959, hs.335205, hs.146406, hs.596783, hs.512973, hs.461030, hs.149983, hs.464137, hs.292524, hs.283749, hs.287362, hs.492203, hs.250693, hs.593232, hs.590575, hs.428214, hs.523847, hs.533712, hs.44067, hs.647072, hs.606472, hs.149032, hs.436705, hs.631539, hs.529353, hs.592020, hs.642938, hs.631930, hs.148907, hs.160556, hs.126891, hs.124011, hs.524828, hs.4779, hs.612872, hs.233240, hs.445030, hs.460, hs.112432, hs.544738, hs.530941, hs.180903, hs.76364, hs.43627, hs.643599, hs.125038, hs.131342, hs.512767, hs.631974, hs.112873 and hs.6217;example, group b: gene, which correspond to transcripts that, with the following the unigene - id - nos.. are connected: hs.72550, hs.528299, hs.510078,..